Segulah IV’s portfolio company CCS Healthcare acquires Propyless
CCS Healthcare has entered into an agreement with Merck Sharp & Dohme (Sweden) to acquire the pharmaceutical skin care product and trademark Propyless. Propyless is a lotion, based on active substance propylene glycol, used for dry skin, atopic dermatitis and psoriasis. Introduced in the late 1980s it is a well-known
